Long non-coding RNA LOC107985656 represses the proliferation of hepatocellular carcinoma cells through activation of the tumor-suppressive Hippo pathway

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70:7–30.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Colombet M, Soerjomataram I, et al. Cancer statistics for the year 2020: an overview. International journal of cancer; 2021. PMID: 33818764. doi: 10.1002/ijc.33588
   Google Scholar
• Singh S, Singh PP, Roberts LR, et al. Chemopreventive strategies in hepatocellular carcinoma. Nat Clin Pract Gastroenterol Hepatol. 2014;11:45–54.
   Google Scholar
• Sato M, Tateishi R, Yatomi Y, et al. Artificial intelligence in the diagnosis and management of hepatocellular carcinoma. J Gastroenterol Hepatol. 2021;36:551–560.
   PubMed Web of Science ®Google Scholar
• Gomaa AI. Recent advances in multidisciplinary management of hepatocellular carcinoma. World J Hepatol. 2015;7:673–687.
   PubMed Web of Science ®Google Scholar
• Clark T, Maximin S, Meier J, et al. Hepatocellular Carcinoma: review of Epidemiology, Screening, Imaging Diagnosis, Response Assessment, and Treatment. Curr Probl Diagn Radiol. 2015;44:479–486.
   PubMed Web of Science ®Google Scholar
• Maass PG, Luft FC, Bähring S. Long non-coding RNA in health and disease. J Mol Med (Berl). 2014;92:337–346.
   PubMed Web of Science ®Google Scholar
• Peng WX, Koirala P, Mo YY. LncRNA-mediated regulation of cell signaling in cancer. Oncogene. 2017;36:5661–5667.
   PubMed Web of Science ®Google Scholar
• Lorenzi L, Avila Cobos F, Decock A, et al. Long noncoding RNA expression profiling in cancer: challenges and opportunities. Genes Chromosomes Cancer. 2019;58:191–199.
   PubMed Web of Science ®Google Scholar
• Bolha L, Ravnik-Glavač M, Glavač D. Long Noncoding RNAs as Biomarkers in Cancer. Dis Markers. 2017;2017:7243968.
   PubMed Web of Science ®Google Scholar
• Schmitz SU, Grote P, Herrmann BG. Mechanisms of long noncoding RNA function in development and disease. Cell Mol Life Sci. 2016;73:2491–2509.
   PubMed Web of Science ®Google Scholar
• Huang Z, Zhou JK, Peng Y, et al. The role of long noncoding RNAs in hepatocellular carcinoma. Mol Cancer. 2020;19:77.
   PubMed Web of Science ®Google Scholar
• Lim LJ, Wong SYS, Huang F, et al. Roles and Regulation of Long Noncoding RNAs in Hepatocellular Carcinoma. Cancer Res. 2019;79:5131–5139.
   PubMed Web of Science ®Google Scholar
• Zhang M, Zhu W, Haeryfar M, et al. Long Non-Coding RNA TRG-AS1 Promoted Proliferation and Invasion of Lung Cancer Cells Through the miR-224-5p/SMAD4 Axis. Onco Targets Ther. 2021;14:4415–4426.
   PubMed Web of Science ®Google Scholar
• Wang H, Di X, Bi Y, et al. Long non-coding RNA LINC00649 regulates YES-associated protein 1 (YAP1)/Hippo pathway to accelerate gastric cancer (GC) progression via sequestering miR-16-5p. Bioengineered. 2021;12:1791–1802.
   PubMed Web of Science ®Google Scholar
• Liu W, Huang Y, Wang D, et al. MPDZ as a novel epigenetic silenced tumor suppressor inhibits growth and progression of lung cancer through the Hippo-YAP pathway. Oncogene. 2021;40:4468–4485.
   PubMed Web of Science ®Google Scholar
• Tan S, Zhao Z, Qiao Y, et al. Activation of the tumor suppressive Hippo pathway by triptonide as a new strategy to potently inhibit aggressive melanoma cell metastasis. Biochem Pharmacol. 2021;185:114423.
   PubMed Web of Science ®Google Scholar
• Hong AW, Meng Z, Guan KL. The Hippo pathway in intestinal regeneration and disease. Nat Clin Pract Gastroenterol Hepatol. 2016;13:324–337.
   Google Scholar
• Plouffe SW, Hong AW, Guan KL. Disease implications of the Hippo/YAP pathway. Trends Mol Med. 2015;21:212–222.
   PubMed Web of Science ®Google Scholar
• Mo JS, Park HW, Guan KL. The Hippo signaling pathway in stem cell biology and cancer. EMBO Rep. 2014;15:642–656.
   PubMed Web of Science ®Google Scholar
• Liu H, Du S, Lei T, et al. Multifaceted regulation and functions of YAP/TAZ in tumors (Review). Oncol Rep. 2018;40:16–28.
   PubMed Web of Science ®Google Scholar
• Gu H, Gu S, Zhang X, et al. miR-106b-5p promotes aggressive progression of hepatocellular carcinoma via targeting RUNX3. Cancer Med. 2019;8:6756–6767.
   PubMed Web of Science ®Google Scholar
• Shi DM, Bian XY, Qin CD, et al. miR-106b-5p promotes stem cell-like properties of hepatocellular carcinoma cells by targeting PTEN via PI3K/Akt pathway. Onco Targets Ther. 2018;11:571–585.
   PubMed Web of Science ®Google Scholar
• Yu LX, Zhang BL, Yang MY, et al. MicroRNA-106b-5p promotes hepatocellular carcinoma development via modulating FOG2. Onco Targets Ther. 2019;12:5639–5647.
   PubMed Web of Science ®Google Scholar
• Liang J, Zhi Y, Deng W, et al. Development and validation of ferroptosis-related lncRNAs signature for hepatocellular carcinoma. PeerJ. 2021;9:e11627.
   PubMed Web of Science ®Google Scholar
• Iaccarino I, Klapper W. LncRNA as Cancer Biomarkers. Methods Mol Biol. 2021;2348:27–41.
   PubMedGoogle Scholar
• Calses PC, Crawford JJ, Lill JR, et al. Hippo Pathway in Cancer: aberrant Regulation and Therapeutic Opportunities. Trends Cancer. 2019;5:297–307.
   PubMed Web of Science ®Google Scholar
• Han Y. Analysis of the role of the Hippo pathway in cancer. J Transl Med. 2019;17:116.
   PubMed Web of Science ®Google Scholar
• Maugeri-Saccà M, De Maria R. The Hippo pathway in normal development and cancer. Pharmacol Ther. 2018;186:60–72.
   PubMed Web of Science ®Google Scholar
• Zhu C, Li L, Zhao B. The regulation and function of YAP transcription co-activator. Acta Biochim Biophys Sin (Shanghai). 2015;47:16–28.
   PubMed Web of Science ®Google Scholar
• Park JH, Shin JE, Park HW. The Role of Hippo Pathway in Cancer Stem Cell Biology. Mol Cells. 2018;41:83–92.
   PubMed Web of Science ®Google Scholar
• Li FL, Guan KL. The two sides of Hippo pathway in cancer. Semin Cancer Biol. 2021. DOI:10.1016/j.semcancer.2021.07.006
   Web of Science ®Google Scholar
• Song W, Zhang J, Zhang J, et al. Overexpression of lncRNA PIK3CD-AS1 promotes expression of LATS1 by competitive binding with microRNA-566 to inhibit the growth, invasion and metastasis of hepatocellular carcinoma cells. Cancer Cell Int. 2019;19:150.
   PubMed Web of Science ®Google Scholar
• Ni W, Zhang Y, Zhan Z, et al. A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1. J Hematol Oncol. 2017;10:91.
   PubMed Web of Science ®Google Scholar